Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01CX001837-01 |
| Title: | A Randomized Trial of Pioglitazone for the Treatment of Alcohol Use Disorder |
| Principal Investigator: | Eric W. Dieperink |
| Location: | Minneapolis, MN |
| Congressional District Code: | 5 |
| Research Service: | Clinical Science R&D |
| Project Period: | April 2019 - March 2023 |
| FY 2021 Funding Amount: | $231,700 |
| Total Award Amount (all years): |
$882,506 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Alcohol use Disorder (AUD) is common among Veterans and is associated with significant morbidity and mortality. In addition, the direct and indirect cost of AUD in Veterans is significant. Several FDA approved medications are available for the treatment of AUD and are thought to act through inhibitory and excitatory neuronal pathways including gamma-aminobutyric acid (GABA), glutamate and opioid pathways. However, effect sizes are generally small and they are used in a minority of patients. Thus... |